Ignite Creation Date:
2024-05-06 @ 7:55 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06189638
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-03
First Post:
2023-12-06
Brief Title:
Phase II Study to Evaluate Efficacy and Safety of AMP Peptide PL-5 in Mild Infections of Diabetic Foot Ulcers
Sponsor:
Jiangsu ProteLight Pharmaceutical Biotechnology Co Ltd
Organization:
Jiangsu ProteLight Pharmaceutical Biotechnology Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2024-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-06
First Submit QC Date:
December 19 2023
Study First Post Date:
2024-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-23
Last Update Post Date:
2024-01-03
Last Update Post Date Type:
ACTUAL